Who are Sulfate, Magnesium's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): IV Magnesium Sulfate, Natrium/ Kalium/ Magnesium sulfate, Magnesium sulphate intramuscular, Sodium 5mEq/kg/day, Magnesium sulfate IV, Sterile Potassium Chloride Concentrate.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/sulfate-magnesium.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Sulfate, Magnesium — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Sulfate, Magnesium (Sulfate, Magnesium) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Electrolyte supplement; anticonvulsant; smooth muscle relaxant. Area: Neurology; Obstetrics; Gastroenterology; Emergency Medicine.

marketed Electrolyte supplement; anticonvulsant; smooth muscle relaxant NMDA receptor antagonist; calcium channel blocker Neurology; Obstetrics; Gastroenterology; Emergency Medicine Small molecule Live · refreshed every 30 min

Target snapshot

Sulfate, Magnesium (Sulfate, Magnesium) — Assistance Publique - Hôpitaux de Paris. Magnesium sulfate acts as a central nervous system depressant and smooth muscle relaxant by blocking calcium influx and stabilizing neuronal membranes.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Sulfate, Magnesium TARGET	Sulfate, Magnesium	Assistance Publique - Hôpitaux de Paris	marketed	Electrolyte supplement; anticonvulsant; smooth muscle relaxant	NMDA receptor antagonist; calcium channel blocker
IV Magnesium Sulfate	IV Magnesium Sulfate	University Hospitals Cleveland Medical Center	marketed	Electrolyte supplement / anticonvulsant	NMDA receptor antagonist; calcium channel blocker (non-selective)
Natrium/ Kalium/ Magnesium sulfate	Natrium/ Kalium/ Magnesium sulfate	Tomas Bata Hospital, Czech Republic	marketed	Osmotic laxative / Electrolyte supplement
Magnesium sulphate intramuscular	Magnesium sulphate intramuscular	Nishtar Medical University	marketed	Anticonvulsant; electrolyte supplement	NMDA receptor; voltage-gated calcium channels
Sodium 5mEq/kg/day	Sodium 5mEq/kg/day	Hospital del Niño "Dr. Federico Gomez Santos"	marketed	Electrolyte supplement
Magnesium sulfate IV	Magnesium sulfate IV	University of Liege	marketed	Electrolyte supplement / anticonvulsant	NMDA receptor, L-type calcium channels
Sterile Potassium Chloride Concentrate	Sterile Potassium Chloride Concentrate	The Queen Elizabeth Hospital	marketed	Electrolyte supplement / Potassium salt	Potassium ion (K+) / Na+/K+-ATPase pump

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Electrolyte supplement; anticonvulsant; smooth muscle relaxant class)

Assistance Publique - Hôpitaux de Paris · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Sulfate, Magnesium — Competitive Intelligence Brief. https://druglandscape.com/ci/sulfate-magnesium. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing